![]()
药品与普通商品之间,本有一条不容逾越的红线,那就是“国药准字”。借消字号、健字号之便高仿药品包装,以“撞脸”之名蒙混过关,本质是用药品的公信力为低门槛产品背书引流。成本最终由消费者承担,正规药企却维权艰难。乱象根源不在某一个“字号”,而在名称标识、平台审核、行业自律各环节未能守住底线。药品安全事关民生福祉,监管红线不容失守,各环节都应切实扛起责任。(图文/张博森)
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.